Development of indole-3-propionic acid (OXIGON™) for Alzheimer's disease

被引:138
作者
Bendheim, PE [1 ]
Poeggeler, B
Neria, E
Ziv, V
Pappolla, MA
Chain, DG
机构
[1] Mindset Biopharmaceut Ltd, Jerusalem, Israel
[2] Univ Gottingen, D-3400 Gottingen, Germany
[3] Univ S Alabama, Mobile, AL 36688 USA
关键词
Alzheimer's disease; beta-amyloid; oxidative stress; indole-3-propionic acid;
D O I
10.1007/s12031-002-0036-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The accumulation of amyloid-beta and concomitant oxidative stress are major pathogenic events in Alzheimer's disease. Indole-3-propionic acid (IPA, OXIGON(TM)) is a potent anti-oxidant devoid of pro-oxidant activity. IPA has been demonstrated to be an inhibitor of beta-amyloid fibril formation and to be a potent neuroprotectant against a variety of oxidotoxins. This review will summarize the known properties of IPA and outline the rationale behind its selection as a potential disease-modifying therapy for Alzheimer's disease.
引用
收藏
页码:213 / 217
页数:5
相关论文
共 32 条
  • [1] OXIDANTS, ANTIOXIDANTS, AND THE DEGENERATIVE DISEASES OF AGING
    AMES, BN
    SHIGENAGA, MK
    HAGEN, TM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) : 7915 - 7922
  • [2] Mechanisms of DNA oxidation
    Aust, AE
    Eveleigh, JF
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (03): : 246 - 252
  • [3] AGING, ENERGY, AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES
    BEAL, MF
    [J]. ANNALS OF NEUROLOGY, 1995, 38 (03) : 357 - 366
  • [4] VITAMIN-E PROTECTS NERVE-CELLS FROM AMYLOID BETA-PROTEIN TOXICITY
    BEHL, C
    DAVIS, J
    COLE, GM
    SCHUBERT, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) : 944 - 950
  • [5] Potent neuroprotective properties against the Alzheimer β-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid
    Chyan, YJ
    Poeggeler, B
    Omar, RA
    Chain, DG
    Frangione, B
    Ghiso, J
    Pappolla, MA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (31) : 21937 - 21942
  • [6] Antioxidant therapy in neurologic disease
    Delanty, N
    Dichter, MA
    [J]. ARCHIVES OF NEUROLOGY, 2000, 57 (09) : 1265 - 1270
  • [7] Antioxidants, oxidative stress, and degenerative neurological disorders
    Floyd, RA
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (03): : 236 - 245
  • [8] SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
    Iadecola, C
    Zhang, FY
    Niwa, K
    Eckman, C
    Turner, SK
    Fischer, E
    Younkin, S
    Borchelt, DR
    Hsiao, KK
    Carlson, GA
    [J]. NATURE NEUROSCIENCE, 1999, 2 (02) : 157 - 161
  • [9] Carcinogen-induced, free radical-mediated reduction in microsomal membrane fluidity: Reversal by indole-3-propionic acid
    Karbownik, M
    Garcia, JJ
    Lewinski, A
    Reiter, RJ
    [J]. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2001, 33 (01) : 73 - 78
  • [10] Relative efficacies of indole antioxidants in reducing autoxidation and iron-induced lipid peroxidation in hamster testes
    Karbownik, M
    Gitto, E
    Lewiñski, A
    Reiter, RJ
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2001, 81 (04) : 693 - 699